Immunotherapy of Cancer [electronic resource] / edited by Mary L. Disis.
| Call Number | 614.5999 |
| Title | Immunotherapy of Cancer edited by Mary L. Disis. |
| Physical Description | XII, 516 p. 52 illus. online resource. |
| Series | Cancer Drug Discovery and Development |
| Contents | Discovery of Target Molecules for Cancer Immunotherapy by Genetic and Bioinformatic Approaches -- Current Strategies for the Identification of Immunogenic Epitopes of Tumor Antigens -- Current and Future Role of Natural-Killer Cells in Cancer Immunotherapy -- The Role of Immune Monitoring in Evaluating Cancer Immunotherapy -- Statistical Analysis of Immune Response Assays in Cancer Immunotherapy Trials -- DNA Vaccines for Cancer Immunotherapy -- Dendritic Cells -- Different Approaches to Dendritic Cell-Based Cancer Immunotherapy -- Anti-Idiotype Antibody Vaccines for the Immunotherapy of Cancer -- Autologous Tumor-Derived Heat Shock Protein Vaccine as a New Paradigm for Individualized Cancer Therapeutics -- Tumor-Reactive T-Cells for Adoptive Immunotherapy -- T-Cell Adoptive Immunotherapy of Cancer -- Retroviral-Mediated Gene Transfer for Engineering Tumor-Reactive T-Cells -- Harnessing the Potential of Graft-vs-Tumor -- Tumor-Induced Immune Suppression and Immune Escape -- The Tumor Microenvironment -- Manipulation of Lymphocyte Homeostasis for Enhancing Antitumor Immunity -- Fast-Lane Evolution in the Tumor Microenvironment -- Manipulating Immunological Checkpoints to Maximize Antitumor Immunity -- Interleukin-2 as Cancer Therapy -- Biological and Clinical Properties of the Type 1 Interferons -- Promising ?-Chain Cytokines for Cancer Immunotherapy -- The Therapeutic Use of Natural-Killer Cells in Hematological Malignancies -- Antibody Therapy for Solid Tumors -- Antibody Therapy for Non-Hodgkin’s Lymphoma -- Approaches to In Vivo Imaging of Cancer Immunotherapy -- Design Issues for Early-Stage Clinical Trials for Cancer Vaccines -- Monoclonal Antibody Therapy of Cancer. |
| Summary | Major scientific advances in molecular and clinical immunology have produced tremendous growth in our understanding of how cancer is recognized by the immune system, as well as in our ability to control and modulate that recognition. In Immunotherapy of Cancer, expert bench and clinical scientists join forces to concurrently review both the state of the art in tumor immunology and its clinical translation into promising practical treatments. The authors explain in each chapter the scientific basis behind such therapeutic agents as monoclonal antibodies, cytokines, vaccines, and T-cells, and illustrate their clinical manipulation to combat cancer. Additional chapters address statistical analysis-both of clinical trials and assay evaluations-methods for the discovery of antigens, adoptive T-cell therapy, and adaptive and innate immunity. The challenges in clinical trial design, the need for biomarkers of response-such as novel imaging techniques and immunological monitoring-and the new advances and directions in cancer immunotherapy are also fully examined. Comprehensive and cutting-edge, Immunotherapy of Cancer offers immunologists an exhaustive and authoritative survey of cancer immunotherapy, as well as providing a springboard for applying the most important findings in tumor immunology to any basic laboratory program or clinical oncology practice. |
| Added Author | Disis, Mary L. editor. SpringerLink (Online service) |
| Subject | MEDICINE. CANCER RESEARCH. Biomedicine. Cancer Research. |
| Multimedia |
-
Libraries with this item
-
950 BiomedicalandLifeSciences(Springer-11642)
Total Ratings:
0
04505nam a22004575i 4500
001
vtls001568519
003
VRT
005
20170831183700.0
007
cr nn 008mamaa
008
170831s2006 xxu| s |||| 0|eng d
020
$a 9781597450119 $9 978-1-59745-011-9
024
7
$a 10.1385/1597450111 $2 doi
035
$a (DE-He213)978-1-59745-011-9
039
9
$y 201708311837 $z santha
050
4
$a RC261-271
072
7
$a MJCL $2 bicssc
072
7
$a MED062000 $2 bisacsh
082
0
4
$a 614.5999 $2 23
245
1
0
$a Immunotherapy of Cancer $h [electronic resource] / $c edited by Mary L. Disis.
264
1
$a Totowa, NJ : $b Humana Press, $c 2006.
300
$a XII, 516 p. 52 illus. $b online resource.
336
$a text $b txt $2 rdacontent
337
$a computer $b c $2 rdamedia
338
$a online resource $b cr $2 rdacarrier
347
$a text file $b PDF $2 rda
490
1
$a Cancer Drug Discovery and Development
505
0
$a Discovery of Target Molecules for Cancer Immunotherapy by Genetic and Bioinformatic Approaches -- Current Strategies for the Identification of Immunogenic Epitopes of Tumor Antigens -- Current and Future Role of Natural-Killer Cells in Cancer Immunotherapy -- The Role of Immune Monitoring in Evaluating Cancer Immunotherapy -- Statistical Analysis of Immune Response Assays in Cancer Immunotherapy Trials -- DNA Vaccines for Cancer Immunotherapy -- Dendritic Cells -- Different Approaches to Dendritic Cell-Based Cancer Immunotherapy -- Anti-Idiotype Antibody Vaccines for the Immunotherapy of Cancer -- Autologous Tumor-Derived Heat Shock Protein Vaccine as a New Paradigm for Individualized Cancer Therapeutics -- Tumor-Reactive T-Cells for Adoptive Immunotherapy -- T-Cell Adoptive Immunotherapy of Cancer -- Retroviral-Mediated Gene Transfer for Engineering Tumor-Reactive T-Cells -- Harnessing the Potential of Graft-vs-Tumor -- Tumor-Induced Immune Suppression and Immune Escape -- The Tumor Microenvironment -- Manipulation of Lymphocyte Homeostasis for Enhancing Antitumor Immunity -- Fast-Lane Evolution in the Tumor Microenvironment -- Manipulating Immunological Checkpoints to Maximize Antitumor Immunity -- Interleukin-2 as Cancer Therapy -- Biological and Clinical Properties of the Type 1 Interferons -- Promising ?-Chain Cytokines for Cancer Immunotherapy -- The Therapeutic Use of Natural-Killer Cells in Hematological Malignancies -- Antibody Therapy for Solid Tumors -- Antibody Therapy for Non-Hodgkin’s Lymphoma -- Approaches to In Vivo Imaging of Cancer Immunotherapy -- Design Issues for Early-Stage Clinical Trials for Cancer Vaccines -- Monoclonal Antibody Therapy of Cancer.
520
$a Major scientific advances in molecular and clinical immunology have produced tremendous growth in our understanding of how cancer is recognized by the immune system, as well as in our ability to control and modulate that recognition. In Immunotherapy of Cancer, expert bench and clinical scientists join forces to concurrently review both the state of the art in tumor immunology and its clinical translation into promising practical treatments. The authors explain in each chapter the scientific basis behind such therapeutic agents as monoclonal antibodies, cytokines, vaccines, and T-cells, and illustrate their clinical manipulation to combat cancer. Additional chapters address statistical analysis-both of clinical trials and assay evaluations-methods for the discovery of antigens, adoptive T-cell therapy, and adaptive and innate immunity. The challenges in clinical trial design, the need for biomarkers of response-such as novel imaging techniques and immunological monitoring-and the new advances and directions in cancer immunotherapy are also fully examined. Comprehensive and cutting-edge, Immunotherapy of Cancer offers immunologists an exhaustive and authoritative survey of cancer immunotherapy, as well as providing a springboard for applying the most important findings in tumor immunology to any basic laboratory program or clinical oncology practice.
650
0
$a MEDICINE.
650
0
$a CANCER RESEARCH.
650
1
4
$a Biomedicine.
650
2
4
$a Cancer Research.
700
1
$a Disis, Mary L. $e editor.
710
2
$a SpringerLink (Online service)
773
0
$t Springer eBooks
776
0
8
$i Printed edition: $z 9781588295644
830
0
$a Cancer Drug Discovery and Development
856
4
0
$u http://dx.doi.org/10.1385/1597450111
912
$a ZDB-2-SBL
950
$a Biomedical and Life Sciences (Springer-11642)
999
$a VIRTUA
No Reviews to Display
| Summary | Major scientific advances in molecular and clinical immunology have produced tremendous growth in our understanding of how cancer is recognized by the immune system, as well as in our ability to control and modulate that recognition. In Immunotherapy of Cancer, expert bench and clinical scientists join forces to concurrently review both the state of the art in tumor immunology and its clinical translation into promising practical treatments. The authors explain in each chapter the scientific basis behind such therapeutic agents as monoclonal antibodies, cytokines, vaccines, and T-cells, and illustrate their clinical manipulation to combat cancer. Additional chapters address statistical analysis-both of clinical trials and assay evaluations-methods for the discovery of antigens, adoptive T-cell therapy, and adaptive and innate immunity. The challenges in clinical trial design, the need for biomarkers of response-such as novel imaging techniques and immunological monitoring-and the new advances and directions in cancer immunotherapy are also fully examined. Comprehensive and cutting-edge, Immunotherapy of Cancer offers immunologists an exhaustive and authoritative survey of cancer immunotherapy, as well as providing a springboard for applying the most important findings in tumor immunology to any basic laboratory program or clinical oncology practice. |
| Contents | Discovery of Target Molecules for Cancer Immunotherapy by Genetic and Bioinformatic Approaches -- Current Strategies for the Identification of Immunogenic Epitopes of Tumor Antigens -- Current and Future Role of Natural-Killer Cells in Cancer Immunotherapy -- The Role of Immune Monitoring in Evaluating Cancer Immunotherapy -- Statistical Analysis of Immune Response Assays in Cancer Immunotherapy Trials -- DNA Vaccines for Cancer Immunotherapy -- Dendritic Cells -- Different Approaches to Dendritic Cell-Based Cancer Immunotherapy -- Anti-Idiotype Antibody Vaccines for the Immunotherapy of Cancer -- Autologous Tumor-Derived Heat Shock Protein Vaccine as a New Paradigm for Individualized Cancer Therapeutics -- Tumor-Reactive T-Cells for Adoptive Immunotherapy -- T-Cell Adoptive Immunotherapy of Cancer -- Retroviral-Mediated Gene Transfer for Engineering Tumor-Reactive T-Cells -- Harnessing the Potential of Graft-vs-Tumor -- Tumor-Induced Immune Suppression and Immune Escape -- The Tumor Microenvironment -- Manipulation of Lymphocyte Homeostasis for Enhancing Antitumor Immunity -- Fast-Lane Evolution in the Tumor Microenvironment -- Manipulating Immunological Checkpoints to Maximize Antitumor Immunity -- Interleukin-2 as Cancer Therapy -- Biological and Clinical Properties of the Type 1 Interferons -- Promising ?-Chain Cytokines for Cancer Immunotherapy -- The Therapeutic Use of Natural-Killer Cells in Hematological Malignancies -- Antibody Therapy for Solid Tumors -- Antibody Therapy for Non-Hodgkin’s Lymphoma -- Approaches to In Vivo Imaging of Cancer Immunotherapy -- Design Issues for Early-Stage Clinical Trials for Cancer Vaccines -- Monoclonal Antibody Therapy of Cancer. |
| Subject | MEDICINE. CANCER RESEARCH. Biomedicine. Cancer Research. |
| Multimedia |